Sandra Silberman

13.6k citations
41 papers · 6.9k · 4 hit papers · h-index 15

Impact in

Papers in

    • Cancer Treatment and Pharmacology 10
    • Glioma Diagnosis and Treatment 9
    • Chronic Lymphocytic Leukemia Research 3

Sandra Silberman

36 papers receiving 6.6k citations

Sandra Silberman's Hit Papers

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor 2003 · 1.7k citations
1.7k0+8+16Years since publication50010001.5k

Peers

Sandra Silberman
Comparison fields: 5 of 103
  • Gastroenterology 3.3k
  • Pulmonary and Respiratory Medicine 2.9k
  • Hematology 979
  • Genetics 583
  • Oncology 1.4k
Replace Saša Dimitrijević with:
Saša Dimitrijević United States
Laura McGreevey United States
Ajia Town United States
A. van Oosterom Belgium
Jonathan A. Fletcher United States
Jonathan C. Trent United States
Maria Dêbiec‐Rychter Belgium
Herlinde Dumez Belgium
Axel Le Cesne France
Scott M. Schuetze United States
Sandra Silberman relative to Saša Dimitrijević United States Saša Dimitrijević's profile →
Citations per field
00.5×1.5×1.8×
Saša Dimitrijević · 1×
Citations per year

Countries citing papers authored by Sandra Silberman

Since Specialization
Citations

This map shows the geographic impact of Sandra Silberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Silberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Silberman more than expected).

Fields of papers citing papers by Sandra Silberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Silberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Silberman. The network helps show where Sandra Silberman may publish in the future.

Co-authors

The 25 scholars most cited alongside Sandra Silberman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandra Silberman Line = papers co-authored together Sandra Silberman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Hit paper breakdown →
20031727
2
Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
Hit paper breakdown →
20011529
3
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
Hit paper breakdown →
2001975
4
Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies
Hit paper breakdown →
2001831
5 2002452
6 2002451
7 2003374
8
Phase II study of imatinib in patients with small cell lung cancer.
2003141
9 201269
10 202367
11 202063
12 200048
13 200228
14 199724
15 200322
16 197814
17 20239
18 20237
19
The interaction of CD4 with HIV-1 gp120.
19916
20 20215

About Sandra Silberman

Sandra Silberman is a scholar working on Oncology, Genetics, Hematology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 41 papers that have together received 6.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Glioma Diagnosis and Treatment (9 papers), Gastrointestinal Tumor Research and Treatment (8 papers), Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Brain Metastases and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and HIV Research and Treatment (3 papers). The work is most often cited by research in Gastroenterology (3.3k citations), Pulmonary and Respiratory Medicine (2.9k citations), Hematology (979 citations), Genetics (583 citations) and Oncology (1.4k citations). Sandra Silberman has collaborated with scholars based in United States, Switzerland and Poland. Frequent co-authors include Saša Dimitrijević, Heikki Joensuu, Peter Roberts‎, George D. Demetri, Brian Druker, Christopher D.�M. Fletcher, Renaud Capdeville, Pekka Tervahartiala, David A. Tuveson and Maarit Sarlomo‐Rikala. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Blood, European Journal of Cancer and Neuro-Oncology Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact